Cofoe Medical Technology Co (301087.SZ) Stock Price
Cofoe Medical Technology Co Price
Over the last 7 years Cofoe Medical Technology Co grew revenue by 17.6% annually, reaching 3.39 B CNY. Earnings per share have grown at 27.9% per year over the last 7 years. For Cofoe Medical Technology Co, the net margin of 11.0% is down versus 18.8% a few years ago. At today's price the dividend yield works out to roughly 3.46%. The payout ratio is around 101% of earnings. The dividend has grown at 4.0% per year over the past 3 years. The consensus 12-month price target for Cofoe Medical Technology Co is 54.92 CNY, about 5.5% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus.
Cofoe Medical Technology Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Cofoe Medical Technology Co business model & stock analysis
Frequently asked questions about Cofoe Medical Technology Co
Analysts currently set an average price target of 54.92 CNY for the Cofoe Medical Technology Co stock (median: 54.92 CNY), implying +5.5 % versus the latest price. The consensus is based on 6 analyst ratings.
6 analysts currently rate the Cofoe Medical Technology Co stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Cofoe Medical Technology Co to generate revenue of 4.35 B CNY and earnings per share of 1.97 CNY.
Converted at the current exchange rate, the Cofoe Medical Technology Co share trades at 6.93 EUR (52.04 CNY).
The expected revenue of Cofoe Medical Technology Co is 4.35 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cofoe Medical Technology Co is 410.85 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cofoe Medical Technology Co is currently 26.46. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cofoe Medical Technology Co stock.
The price-to-sales ratio (P/S) of Cofoe Medical Technology Co is currently 2.50. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cofoe Medical Technology Co stock.
The Eulerpool Quality Score for Cofoe Medical Technology Co is 3/10.
The ISIN of Cofoe Medical Technology Co is CNE100004Y98. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Cofoe Medical Technology Co is 301087.SZ. The ticker symbol is used to trade Cofoe Medical Technology Co shares on the stock exchange.
Cofoe Medical Technology Co stock
Cofoe Medical Technology Co Peer Group
Cofoe Medical Technology Co FIGI
All fundamentals and in-depth analysis of Cofoe Medical Technology Co
Our stock analysis for Cofoe Medical Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cofoe Medical Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.